HRP941012A2 - Steroidal glycosides - Google Patents

Steroidal glycosides Download PDF

Info

Publication number
HRP941012A2
HRP941012A2 HR08/174,100A HRP941012A HRP941012A2 HR P941012 A2 HRP941012 A2 HR P941012A2 HR P941012 A HRP941012 A HR P941012A HR P941012 A2 HRP941012 A2 HR P941012A2
Authority
HR
Croatia
Prior art keywords
oxy
cellobiosyl
spirostan
compound according
bis
Prior art date
Application number
HR08/174,100A
Other languages
English (en)
Croatian (hr)
Inventor
Michael Paul Deninno
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HRP941012A2 publication Critical patent/HRP941012A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
HR08/174,100A 1993-12-28 1994-12-22 Steroidal glycosides HRP941012A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17410093A 1993-12-28 1993-12-28

Publications (1)

Publication Number Publication Date
HRP941012A2 true HRP941012A2 (en) 1997-08-31

Family

ID=22634820

Family Applications (1)

Application Number Title Priority Date Filing Date
HR08/174,100A HRP941012A2 (en) 1993-12-28 1994-12-22 Steroidal glycosides

Country Status (11)

Country Link
US (1) US5698526A (fr)
EP (1) EP0737203A1 (fr)
AU (1) AU7948494A (fr)
CA (1) CA2180149A1 (fr)
CO (1) CO4230021A1 (fr)
FI (1) FI946106L (fr)
HR (1) HRP941012A2 (fr)
IL (1) IL112117A0 (fr)
MA (1) MA23412A1 (fr)
PE (1) PE49295A1 (fr)
WO (1) WO1995018144A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI970828L (fi) * 1994-08-30 1997-02-27 Pfizer Spirostanyyliglykosidien kiteitä
WO1996038466A1 (fr) * 1995-05-29 1996-12-05 Pfizer Inc. Glycosides steroidiques
US5698527A (en) * 1995-08-08 1997-12-16 Merck & Co., Inc. Steroidal glycosides as antihyperlipidemic agents
PL195897B1 (pl) * 1998-03-26 2007-11-30 Phytopharm Plc Zastosowanie smilageniny
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
US6635490B1 (en) 2000-05-25 2003-10-21 Noble Laboratories Procedure for the simultaneous quantitative and qualitative analysis of both flavonoid glycosides and steroidal glycosides
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
CN102727501A (zh) * 2002-03-27 2012-10-17 菲特法姆股份有限公司 皂角苷配基及其衍生物的用途
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
GB0220198D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Modified saccharides,conjugates thereof and their manufacture
KR101646960B1 (ko) 2007-10-16 2016-08-09 프로젠 피지500 시리즈 피티와이 리미티드 신규한 황산화된 올리고사카라이드 유도체

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2024624A (en) * 1978-07-05 1980-01-16 Roecar Holdings Nv Anti inflammatory spiroketalins
DE2926463A1 (de) * 1978-07-05 1980-01-24 Roecar Holdings Nv Spiroketaline und ihre verwendung
US4602005A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis
US5629295A (en) * 1992-06-26 1997-05-13 Pfizer Inc. Steroidal glycosides for treating hypercholesterolemia
EP0647233A1 (fr) * 1992-06-26 1995-04-12 Pfizer Inc. PROCEDE DE SYNTHESE DE $g(b)-O-CELLOBIOSIDE HEPTAALCANOATE STEROIDIEN

Also Published As

Publication number Publication date
CA2180149A1 (fr) 1995-07-06
FI946106A0 (fi) 1994-12-27
CO4230021A1 (es) 1995-10-19
WO1995018144A1 (fr) 1995-07-06
MA23412A1 (fr) 1995-07-01
IL112117A0 (en) 1995-03-15
AU7948494A (en) 1995-07-17
FI946106A7 (fi) 1995-06-29
PE49295A1 (es) 1996-01-09
EP0737203A1 (fr) 1996-10-16
US5698526A (en) 1997-12-16
FI946106L (fi) 1995-06-29

Similar Documents

Publication Publication Date Title
US5939398A (en) Hypocholesterolemic agents
HRP941012A2 (en) Steroidal glycosides
US5629295A (en) Steroidal glycosides for treating hypercholesterolemia
NZ245244A (en) Preparation of tigogenin-; 11-ketotigogenin-, hecogenin-, and diosgenin-beta-0-cellobioside heptaalkanoate from the relevant steroid in the presence of zinc fluoride or cyanide
EP0147777A2 (fr) Dérivés d'amides d'acides carboxyliques M-glycosylés comme produit pour combattre les maladies de type rheumatismal
US4248791A (en) 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
JP2783560B2 (ja) 新規なアンドロスタン１７−カルボン酸エステル、その製法及びそれを含む薬剤
US6150336A (en) Steroidal glycosides
Wang et al. Synthesis of two bidesmosidic ursolic acid saponins bearing a 2, 3-branched trisaccharide residue
EP0696292A1 (fr) Monohydrate cristallin glycosidique de spirostanyle
Cheng et al. Synthesis of flaccidoside II, a bidesmosidic triterpene saponin isolated from Chinese folk medicine Di Wu
EP0044227B1 (fr) 11-Alpha-amino androstanes, compositions pharmaceutiques les contenant et procédés pour les préparer
JPH09500907A (ja) ステロイドグリコシド
US6114318A (en) 17β-(2-oxo-tetrahydrofuranyl)-thio- substituted androstane derivatives
EP0066467B1 (fr) 11-Alpha-amino androstanes
US5530107A (en) Method for making steroidal peracyl glycosides
DE69326023T2 (de) Neue colon-oder ilean-spezifische steroid derivate
US20110054156A1 (en) Synthesis of timosaponin bii
US4659704A (en) 19-hydroxyaldosterone and its preparation
NZ199859A (en) 11alpha-amino-3beta-hydroxy-androstanes
US20070135358A1 (en) Steroid modified solatrioses
CH505809A (de) Verfahren zur Herstellung 1(10)-5-oxo-5,10-Seco-steroiden

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
OBST Application withdrawn